Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2, 1-b][1, 3]oxazepin-8-olate | Patent Publication Number 20160016973
US 20160016973 A1Patent NumberUS 09708342 B2
Application Number14744915
Filled DateJun 19, 2015
Priority DateJun 20, 2014
Publication DateJan 21, 2016
Original AssigneeGilead Sciences
Current AssigneeGilead Sciences
Inventor/ApplicantsVahid Zia
Ernest A. Carra
Irene Chen
Ernest A. Carra
Irene Chen
![Patent Prosecution report image](/_next/image?url=https%3A%2F%2Fpatexia-data.s3.amazonaws.com%2Fconnect%2F65256ba2e3fa03282001bdac%2F280_c4899fec3f1140f6f1ec05c01211cc01.jpg&w=384&q=75)
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.